Every breakthrough in pharma and biotech runs on software: molecular modelling tools, lab informatics platforms, statistical packages and engineering applications all help move a discovery from the bench to the patient. But behind that innovation sits a question that often goes unanswered:

How much of that software is actually being used?

Licenses bought for a project that has since wrapped up. Seats assigned to users who log in once a quarter. Expensive tools sitting idle while another team asks for more. Without clear usage data, these gaps stay hidden, and so do the costs that come with them.

In this webinar, we will show how pharmaceutical and biotech companies use OpenLM to turn that uncertainty into insight. You’ll see how to get a clear view of software usage, spot idle licenses, optimise utilisation and reduce licensing costs, all based on real data rather than assumptions.

In this session, you will learn how to:

• See exactly how software licenses are used across teams and sites
• Uncover idle and underused licenses that add to your costs
• Align license capacity with real demand, so the right tools reach the right people
• Prepare for renewal and vendor negotiations with usage evidence on your side

Who should attend: IT and software asset management leaders, license administrators, procurement professionals, and R&D, scientific computing and engineering managers in pharmaceutical and biotech organisations.

Can’t make it live? Register, and we’ll send you the recording.